戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ining the immunogenicity of each IgE binding epitope.
2 uence constitutes a PC-specific neutralizing epitope.
3 tor target, but by recognition of a distinct epitope.
4 s and neutralization than the native peptide epitope.
5 sociated with the general variability of the epitope.
6 like receptors, and allotypes having neither epitope.
7  ELISAs, probably via exposure of additional epitopes.
8  from children and adults reacted to unknown epitopes.
9 arly identical profile of cross-neutralizing epitopes.
10 ssed ligands, cancer neoantigens, and T cell epitopes.
11 of different PGs and their assorted sulfated epitopes.
12 enicity breakthrough to conserved protective epitopes.
13 ssible state and which expose V1V2 and/or V3 epitopes.
14 e CRD to glycans that contain Manalpha1-2Man epitopes.
15 lycan, indicating an overlap between the two epitopes.
16  primarily due to the inaccessibility of the epitopes.
17 CD8(+) T cell response to two immunodominant epitopes.
18 izing epitopes and few to no nonneutralizing epitopes.
19 liminated the induction of tier-1 NAbs to V3-epitopes.
20 ontains important CD8(+), CD4(+), and B cell epitopes.
21 n to automatically extract reactive chemical epitopes.
22  B cells that recognize broadly neutralizing epitopes.
23 d further to incorporate specific biological epitopes.
24  capture of the physiological immunodominant epitopes.
25 ics to focus vaccine responses on protective epitopes.
26 as an intact protein bearing multiple linear epitopes.
27                                  Patterns of epitope abundance and the sequential release of cell wal
28                               A total of 106 epitopes accounted for half of the total T cell response
29        The two other VHHs, E1 and V1C7, bind epitopes adjacent to V5E1 but display only weak toxin ne
30 efore, we set out to map H2-IA(b)-restricted epitopes along the PVM proteome.
31 ceptors of NK cells, allotypes having the C1 epitope also recognized by killer cell Ig-like receptors
32                                 As IgE glyco-epitopes, also referred to as cross-reactive carbohydrat
33 ay explain the genetic conservation of these epitopes among flaviviruses.
34 on-associated spikes present nearly all bnAb epitopes and are therefore promising vaccine antigens.
35 n of 836 bp, which contains the major immune epitopes and drug resistance mutations.
36 brid molecule was designed to cover relevant epitopes and evaluated in silico.
37  displays predominantly broadly neutralizing epitopes and few to no nonneutralizing epitopes.
38 xplain amino acid preferences in immunogenic epitopes and highlight opportunities for structural cons
39 e human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown
40 d activation of gB through different surface epitopes and mechanisms.
41       The RBD contains critical neutralizing epitopes and serves as an important vaccine target.
42 matically reduces exposure of CD4i HIV-1 Env epitopes and therefore reduce the susceptibility of HIV-
43 perimental data (analysis of guard cell wall epitopes and treatment of tissue with cell wall digestin
44 ased on a random forest algorithm trained on epitopes annotated from antibody-antigen protein structu
45 rum IgE antibodies directed to the alpha-gal epitope are associated with hypersensitivity to equine a
46 er of clones for the CTL response against an epitope are inversely associated with the general variab
47    SEPIa was applied to a test protein whose epitopes are known, human beta2 adrenergic G-protein-cou
48 lexes shows that the conserved neuraminidase epitopes are located on the head of the molecule and tha
49 ponses, such as those against oxidized lipid epitopes, are thought to mainly derive from T cell-indep
50  support the feasibility of exploring the V3 epitope as a HIV-1 vaccine target in nonhuman primates.
51 rrelated with Abs that reacted with a linear epitope at a lysine residue at position 169 (K169) in th
52 of the most potent bnAbs target a quaternary epitope at the apex of the surface HIV envelope (Env) tr
53                                   Quaternary epitopes at the apex of the spike are recognized by some
54 e vaccine candidate, but variation in B-cell epitopes at the dimer interface of DBP leads to inductio
55 ts of protective immunity are conformational epitopes at the dimer interface.
56 f effector memory CD8 T cells, regardless of epitope avidity.
57 monstrate that ectopic expression of insulin epitope B:9-23 (InsB9-23) by thymic APCs is insufficient
58                                              Epitope-based matching has been applied not only to iden
59  restored the immunoreactivity of mAbs whose epitope being within residues 44-65 against reconstitute
60                               Cross-reactive epitopes bind with higher affinity to alpha/beta dimers
61                                              Epitope binding affinities were mapped for human cross-r
62 phA2 internalization rate, binding affinity, epitope binding, and hydrophobicity.
63  basophil activation tests, determination of epitope binding, DNA methylation signatures, and bioinfo
64                                              Epitope binning studies showed that the majority of neut
65  (JUNV GP1-GD01) reveals largely overlapping epitopes but highly distinct antibody-binding modes.
66 emonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologo
67 we report the identification of an energetic epitope by determining the interfacial hot-spot that dom
68             Structural mimicry of the DENV E epitope by the E1 combining site is achieved via the for
69 at focus on conserved elements of the target epitope, by thwarting strain-specific and distracted lin
70 ide evidence that antibody binding to a PorB epitope can be altered by sequence mutations in non-epit
71 mmune recognition of capsular polysaccharide epitopes can aid in the design of novel glycoconjugate v
72 n of red blood cells expressing self-antigen epitopes can alleviate and even prevent signs of disease
73  containing lethal mutations upstream of CTL epitopes can also be recognized by CTLs, potentially thr
74 GFR Abs directed against clinically relevant epitopes can be converted into mAb with unprecedented CD
75 ecognize this relatively featureless peptide epitope (canonical TCRs).
76 s revealed that the targeted type III repeat epitopes cluster on the inner strands of both beta-sheet
77 nternal destructive cleavages within the ALY epitope compared with the constitutive proteasome.
78 ty depends on the recognition of MHC class I-epitope complexes at the cell surface.
79 igens and predicted cross-reactive microbial epitopes, consistent with neoantigen molecular mimicry.
80               After identification of T cell epitope-containing parts on each of the 3 parental aller
81 le to identify a MHCII-restricted CD4 T cell epitope, corresponding to amino acids 37-47 in the PVM m
82                                      The 5B4 epitope corresponds to a peptide sequence (I56-K68) over
83 e of these V2 Abs revealed how the linear V2 epitope could be engaged, despite the lack of aspartic a
84 e novo design of antibodies binding specific epitopes could greatly accelerate discovery of therapeut
85 or sequence-based epitope prediction both on epitope data derived from solved 3D structures, and on a
86 lts in the majority of the latest two Immune Epitope Database (IEDB) weekly automated benchmark datas
87      The antibodies reduced tau uptake in an epitope-dependent manner: N-terminal (Tau13) and middoma
88           IgE and IgG4 binding to sequential epitopes derived from five major CM proteins were measur
89 boosted with molecules containing the B cell epitope-derived peptide without carrier or linked to oth
90  Tara) to be another such protein through an epitope discovery and proteomics approach by comparing p
91 eutralizing antibodies that targeted similar epitope domains at the EDI/II hinge region.
92 uctures, and on a large collection of linear epitopes downloaded from the IEDB database.
93 se mutations is able to generate and present epitopes downstream of the termination codon.
94 that mutations at the C-terminal end of this epitope dramatically improve presentation to these T cel
95 formational change in a loop within the PL-2 epitope due to a serine-to-proline mutation, locking the
96  in mice, those recognizing the DENV E-dimer epitope (EDE) can neutralize ZIKV infection in cell cult
97 proposal that prolonged exposure of the bNAb epitope enabled the maturation of the bNAb lineage.
98 entially be leveraged in HIV cure efforts if epitope escape and lack of sustained effector memory res
99  both CD4 reactivity and CD4-induced non-nAb epitope exposure, and increase thermal stability while m
100 n the immediate-early MCMV gene ie2 The same epitope expressed within the early M45 gene provided no
101 CA2a 971-990 can potentially act as a common epitope for both T cells and B cells.
102 ble multivalent display of potential allergy epitopes for determining the immunogenicity of each IgE
103 f three peptides that include immunodominant epitopes for gluten-specific CD4-positive T cells.
104 ulent PEDV, but the virus may lose important epitopes for inducing robust protective immunity.IMPORTA
105  first generation native-like trimers expose epitopes for non-neutralizing antibodies (non-nAbs), whi
106                           Even if FaEO lacks epitopes for stable or transient membrane-interactions,
107 C1, 3B10, and 2H7, which recognize different epitopes, for further evaluation.
108 dase coupled with MALDI-MS allowed these two epitopes, for the first time, to be directly identified
109 ve mass spectrometric analyses to define the epitopes formed in tolerant and hypersensitive patients
110 ariants of p145, a conserved helical peptide epitope from the M protein of Streptococcus pyogenes, we
111 eukocyte antigen (HLA)-E and specific for an epitope from UL40 (VMAPRTLIL), which is characterized by
112 alysis of CD8+ T cells specific for a single epitope from Yellow Fever Virus (YFV), we show that the
113 lved sophisticated strategies to conceal Env epitopes from ADCC-mediating antibodies present in HIV+
114 ds to very few representative immunodominant epitopes from pathogenic insults.
115 tential HLA-A*02:01-restricted CD8(+) T-cell epitopes from the 693-amino-acid sequence of the VP13/14
116 rays of synthetic oligosaccharides, the LM26 epitope has been identified as a beta-1,6-galactosyl sub
117 hput methods that generate vast libraries of epitopes have been applied.
118 nogens produced robust antibody responses to epitope I, and their serum could neutralize HCV.
119 combinant vaccinia virus expressing the same epitope if KCSRNRQYL is expressed within the immediate-e
120 nly 13% of sample pairs sharing at least one epitope in alphas1 -casein to 73% in kappa-casein.
121 ng preferences and present the alpha3135-145 epitope in different binding registers.
122       Insertion of a 9-residue hemagglutinin epitope in IS1S2, but not in IS5S6 or in IIS5S6, prevent
123 sponses to the Plasmodium berghei GAP5040-48 epitope in mice expressing the MHC class I allele H-2D(b
124    We also identify a conserved inflammatory epitope in related proteins from diverse families, and d
125 an anti-iC3b mAb that was shown to target an epitope in the CUB region.
126  to a complex, 3-monomer spanning quaternary epitope in the DENV3 envelope (E) protein, but it is unc
127 tations destroying the conserved fusion-loop epitope in the E protein.
128 eloped higher IgG responses against a linear epitope in the gp120 C1 region of the HIV-1 envelope gly
129                    46B8 binds to a conserved epitope in the vestigial esterase domain of hemagglutini
130 immunofluorescence studies indicate that MLG epitopes in brown algae are unmasked by a pre-treatment
131                                          Two epitopes in CFP-10 were characterized, and the MHC class
132 alleles for immunodominant Gag CD4(+) T cell epitopes in clade C virus infection, constructed MHC cla
133 nto these processes, 27 antibodies targeting epitopes in CMV virion glycoprotein complexes, including
134 ntibodies that target conserved neutralizing epitopes in E2 (HC33.4, HC84.26, and AR3B) and the E1E2
135  immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enha
136 anti-SEE antibodies recognize nonoverlapping epitopes in SEE.
137 e genetic restrictions identified within the epitopes in the EDII fusion loop likely explain the sequ
138 ch protein component masked the IgE-reactive epitopes in the other protein component more effectively
139 alizing antibodies targeting CD4-induced Env epitopes in the presence of soluble CD4 (sCD4).
140 like trimers that reduce exposure of non-nAb epitopes in the V3-loop and trimer base, minimize both C
141 s, indicating that RSV F internalization was epitope independent.
142 pe microspores contained primexine-localized epitopes indicative of the presence of xylan, but these
143 arger portions of the DENV3-specific 5J7 mAb epitope into dengue virus serotype 4 (DENV4).
144                  This functionally conserved epitope is a potential target for vaccines against P. fa
145  hinge-spanning region of the 5J7 quaternary epitope is a target for serotype-specific neutralizing a
146 actions and confirms that the conformational epitope is not required for antigen recognition.
147 lic (Allium sativum) bulbs in which the LM26 epitope is widespread throughout most cell walls includi
148 s engineered to improve exposure of specific epitopes is critical for HIV-1 vaccine development.
149 e ability to monitor the occurrence of these epitopes is important as structural changes are associat
150      In this study we tested the low-avidity epitope KCSRNRQYL, and show that a mouse CMV (MCMV) vect
151 ng the identical HLA-B*2705-restricted HIV-1 epitope KK10 (KRWIILGLNK).
152 57727-734, and the normally subdominant LCMV epitope L2062-2069, indicating a profound private specif
153 ray crystallography and EM to identify their epitope locations.
154 ertoire of 29 CTL responses against 23 HIV-1 epitopes longitudinally in nine chronically infected unt
155  loops both adjacent and non-adjacent to the epitope loop can enhance or diminish antibody binding, a
156  can be altered by sequence mutations in non-epitope loops.
157                            T-cell responses, epitope mapping and cross-reactivity to profilins (Phl p
158 ells were determined by a novel CD154 T cell epitope mapping assay.
159 arrays were generated to enable the detailed epitope mapping of two monoclonal antibodies known to re
160                                              Epitope mapping was performed by pepscan analysis, site-
161                                     Previous epitope-mapping of autoantibodies (AutoAbs) from prostat
162 ues of E1E2 also resulted in identifying the epitope maps of diverse mAbs and the disulfide connectiv
163 R spectroscopy is extensively used to obtain epitope maps of ligands binding to protein receptors, th
164 oclonal antibodies (NAbs) targeting distinct epitopes may be necessary for protective immunity.
165 ized alloimmune risk determined by HLA-DR/DQ epitope mismatch.
166  shorter sequences and occupy nonoverlapping epitopes more frequently than aptamers with single modif
167 we identified a pathogenic CD8(+) T cell MPO epitope (MPO431-439) and found that cotransfer of MPO431
168                               Infectious HCV epitope mutants encoding the well-defined genotype 1a-de
169  These results show that CTLs constantly lag epitope mutation, suggesting that preventing HIV-1 escap
170 ques have been used to prove the "junctional epitope" nature of VHH6, a camelid single domain antibod
171 alization by MAbs targeting the neutralizing epitope (NE) antigenic site.
172 oth antibodies bound to quaternary structure epitopes near the hinge region between envelope protein
173          Four antibodies reacted with linear epitopes near the N terminus of gH, exhibited strain spe
174 found that both HVEM and UL144 bind a common epitope of BTLA, whether engaged in trans or in cis, tha
175  results identify differences in the binding epitope of cytb 5 in the presence and absence of membran
176 erent residue types to map integratively the epitope of human interleukin-6 receptor (IL-6R) for two
177 response of EF4.1 mice to an I-Ab-associated epitope of the F-MuLV envelope protein is dominated by c
178 one of these sites broadly overlaps with the epitope of the well-known 4B7 mouse antibody, which can
179       Thus, sequence homology between T cell epitopes of 2 self-proteins and a related order of gut m
180 vivo model of TCD8 responses to well-defined epitopes of a clinically relevant oncoprotein, large T A
181 extracts is mainly related to bromelain-type epitopes of a newly identified cypress PG.
182 ry, Abseq uses specific antibodies to detect epitopes of interest; however, unlike these methods, ant
183 Rs from T cells that recognize the same pMHC epitope often share conserved sequence features, suggest
184 inding, despite the location of the antibody epitope on a domain (Ig1) not reported to bind NK1 or HG
185  Ab that selectively recognize the alpha-gal epitope on BGG.
186 -determining regions to bind to a quaternary epitope on each side of the dimeric capsid spike.
187 oparticles (immunogold) to map the available epitopes on a transferrin grafted silica particle (SiO2-
188 riants obtained by evolving murine antigenic epitopes on an AAV serotype 1 capsid template can evade
189   In this study, we mapped and characterized epitopes on DENV4 recognized by neutralizing antibodies
190 xin, suggesting that human B cells recognize epitopes on the dimerized form of LukAB during natural i
191 tructural features (measured by integrity of epitopes on the Env trimer) in a geographically defined
192  the gap in knowledge of protective antibody epitopes on the HAstV capsid surface.
193                              A CD8(+) T cell epitope peptide from OVA (CSIINFEKL) and CpG were co-con
194 b-dependent cellular phagocytosis favored an epitope positioned further away.
195 orm other available tools for sequence-based epitope prediction both on epitope data derived from sol
196 ed on several bioinformatic tools for linear epitope prediction, a set of seven peptides was successf
197 limitations of SEPIa and of all other B-cell epitope predictors are discussed.
198 he induction of CD4 T cell responses and the epitope preferentially binds MHC class II/IA(k) rather t
199  5B4 and 6H4 recognize structurally distinct epitopes present in the vast majority of Bet v 1 isoform
200 ying the contribution of factors critical to epitope presentation, such as protein cleavage and gene
201 e cells respond to an insulin B-chain (InsB) epitope presented by the HLA-DQ8 molecule associated wit
202 accine, based on priming with multiple ASYMP epitopes (prime) and neurotropic TG delivery of the T ce
203 ght to investigate whether food-specific IgA epitope profiles differ intra-individually between mothe
204                              VST tracking by epitope profiling revealed persistence of functional VST
205 a single MHC class I-restricted high-avidity epitope provided strong, T cell-dependent protection aga
206                                     Directed epitope rearrangements combined with a knowledge-based s
207       Moreover, since the alpha-(1-4)-glucan epitope recognised by INCh1 is also a component of glyco
208  the apoplastic presence of endogenous auxin epitopes recognised by an anti-IAA antibody.
209 ere we characterized a distinct mode of V1V2 epitope recognition by the new bNAb BG1 in which two Fab
210                             The differential epitope recognition was not due to differences in HLA cl
211 ly, these data reveal an innate-like mode of epitope recognition with potential implications for the
212 ntified a major difference in conformational epitope recognition, with the nonpathogenic infection be
213 n this study, we report the structure of the epitope recognized by a monoclonal antibody with opsonop
214 nt functional type: allotypes having the Bw4 epitope recognized by killer cell Ig-like receptors of N
215                      Characterization of the epitope recognized by protective antibodies may facilita
216 ivotal in the generation of the K-epsilon-GG epitope recognized during IAP, here we developed a large
217                                          The epitopes recognized following rDEN2Delta30 infection and
218                                 The specific epitopes recognized in this study can potentially be tes
219 g that these mAbs specifically recognize the epitope region in a random coil state.
220  structural characterization of these glycan epitopes remains a significant challenge in mAb preclini
221 ll and serum antibody responses with broader epitope representation and greater durability than with
222 ion of DENV NS1 in which host-cross-reactive epitopes reside.
223 e p17 R76G mutant which enables a functional epitope(s), masked in refp17, to elicit B-cell growth-pr
224 thermore, HLA-DR molecules encoded by shared-epitope (SE) alleles were predicted to bind these self-
225  (HLA)-DRB1 gene (HLA-DRB1) encode a "shared epitope" (SE) associated with rheumatoid arthritis (RA),
226 it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenici
227 active between a newly defined putative MCMV epitope sequence, M57727-734, and the normally subdomina
228                  DOSCATs combine a series of epitope sequences concatenated with tryptic peptides in
229                                 However, the epitope sequences within the PC that are recognized by t
230                                          One epitope, SERCA2a 971-990, induces widespread atrial infl
231               These antibodies define common epitopes shared by many viral isolates.
232 bergine glycans contain abundant heteroxylan epitopes, some of which are associated with both pectin
233 rphism shapes the relative abundance of self-epitope specific Treg cells that leads to protection or
234 icroscopy (dSTORM) to show that certain CD4i epitopes specific to transition state structures are exp
235    Our results confirm that a diverse set of epitope-specific AHAs can be isolated from a single huma
236 pt application for the rational design of an epitope-specific antibody binding with the target protei
237  VRC03, VRC-PG04, PGT128, and the quaternary epitope-specific bNAbs PGT145 and PGDM1400.
238                    To determine whether HCMV epitope-specific CD4(+) T cell memory inflation occurs d
239 n determining immunodominance hierarchy, and epitope-specific CD8(+) T cell requirements for costimul
240                   Increased binding of serum epitope-specific IgA to CM in mothers of infants with CM
241           Our analyses demonstrate that each epitope-specific repertoire contains a clustered group o
242 to the generalizable, underlying features of epitope-specific repertoires and adaptive immune recogni
243  Notably, the cyclic designs induced greater epitope-specific responses and neutralization than the n
244  report the in-depth characterization of ten epitope-specific TCR repertoires of CD8(+) T cells from
245 1 and block the Keap1-Nrf2 interaction in an epitope-specific way.
246 humoral assays, we evaluated the magnitudes, epitope specificities, avidities, and functions of syste
247                            Evaluation of the epitope specificities, locations (systemic or mucosal),
248         There was significant discordance in epitope specificity between BM and maternal sera ranging
249 eling of monoclonal AQP4-IgGs with differing epitope specificity bound to isolated tetramers (M1-AQP4
250     Antibody, cellular immune responses, and epitope specificity in sensitized mice were investigated
251 hat it may be possible to predictively model epitope specificity.
252 ugh MCMV vectors expressing the high-avidity epitope SSIEFARL induced protective immunity irrespectiv
253 itive to antibodies targeting nonoverlapping epitopes, such as the anti-CD4-binding-site antibodies 3
254 ted Cas9 protein fused to repetitive peptide epitopes (SunTag) recruiting multiple copies of antibody
255                                  By studying epitope-tagged derivatives of mouse astrotactin-2 (Astn2
256 lymphoblastoid cell lines (LCLs), expressing epitope-tagged EBNA3A, EBNA3B or EBNA3C from EBV-recombi
257          Co-immunoprecipitation studies with epitope-tagged PP1c and Gbeta1 revealed that Gbeta1 inte
258 eneration of sequence-specific mutations and epitope tagging at an endogenous locus.
259 ription factor genes; (3) simple knock-in of epitope tags and fluorescent reporters (e.g. Sox2-V5 and
260 in expressing two Cdc20 genes with different epitope tags, we show by co-immunoprecipitation that thi
261  The neutralizing antibody responses and the epitopes targeted against DENV4 have not been characteri
262 y affinity maturation pathways and divergent epitope targeting.
263 n addition, MSB0010853 contains a third HER3 epitope that binds albumin to extend its circulation tim
264 zed the lateral patch, the principal exposed epitope that did not change when pdm2009 displaced previ
265 , the V2 Ab response was focused on a linear epitope that did not include K169.
266  of the TcdA CROPs helped define a conserved epitope that is distinct from previously identified carb
267 nogens based on the structure of a conserved epitope that is the target of broadly neutralizing antib
268 referential loss of T-cell reactivity to Mtb epitopes that are homologous to bacteria in the microbio
269 inhibited the response to two immunodominant epitopes that are known to be dependent on Ag cross-pres
270                            Identification of epitopes that are recognized by diabetogenic T cells and
271 ptor:chemokine interfaces, and suggest novel epitopes that can be exploited to overcome these challen
272 nt variants, and the presence of distracting epitopes that entropically disfavor the evolution of bnA
273 mino acids within the antigenic determinant (epitope), the whole proteome can be represented by a ran
274 emblies of peptides and the relevant protein epitopes, this work illustrates a bioinspired approach t
275 ed with the glycoprotein B DYSNTHSTRYV (DYS) epitope to characterize circulating CD4(+) T cells in co
276 lls in case of toxicity; and (4) a CD34-CD20 epitope to facilitate selection of the engineered cell p
277  following delivery of its own TonB1-binding epitope to the periplasm.
278  inactivation; and (iii) exposure of cryptic epitopes to antibodies, allowing virus neutralization.
279 tates cross-presentation of disease-relevant epitopes to CD8(+) T cells.
280                 The cross-reactivity of ZIKV epitopes to dengue virus (DENV) was tested using IFN-gam
281 , gamma-gliadins, LMW subunits and antigenic epitopes to gain a better understanding of the technolog
282  of experimentally mapped Der f 1/Der p1 IgG epitopes to the same surface patch on Blo t 1, as well a
283 ique to Zika and Dengue, but also identified epitopes unique to each Dengue serotype.
284   From this analysis, we not only identified epitopes unique to Zika and Dengue, but also identified
285 pecific IgE and challenged with Pen a 1 (IgE epitope valency of >/=8), although measurable responses
286       The composition of TCRs targeting each epitope varied considerably in stability over time, alth
287 NV4/3 virus containing the most expanded 5J7 epitope was also significantly more sensitive than WT DE
288 or histocompatibility complex class (MHC-II) epitope was identified, based on in silico prediction co
289 ility, cluster size and accessibility to myc-epitopes we show that forces acting on the transmembrane
290 ts of immunodominance among several dominant epitopes, we utilized a cell free antigen processing sys
291 d HLA-A2-restricted HCV NS3-1073 or NS5-2594 epitope were generated from a genotype 2a-derived HCV cl
292 t neutralized DENV4 were isolated, and their epitopes were finely mapped using recombinant viruses an
293 lar cytotoxicity favored a membrane-proximal epitope, whereas Ab-dependent cellular phagocytosis favo
294 ldren recognize deamidated and native gluten epitopes, whereas T cells from adults only recognize dea
295 and identify an immune-dominant neutralizing epitope, which can be exploited for vaccine development.
296 y a monomer that does not display quaternary epitopes, which may explain the modest success with solu
297 d not inhibit the response to "inflationary" epitopes whose responses can be sustained by infected no
298 had an immunodominant response to the Gag293 epitope with a functional avidity intermediate between t
299 al antibody (mAb) LE2E9 revealed overlapping epitopes with murine C1-specific group A mAbs including
300 r the discovery of a continuous neutralizing epitope within the UL128 subunit of the PC that could be

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top